Literature DB >> 32282123

The association of hypertension, hypertension duration, and control with incident heart failure in black and white adults.

Matthew T Mefford1, Parag Goyal2, George Howard1, Raegan W Durant1, Nancy E Dunlap1, Monika M Safford2, Paul Muntner1, Emily B Levitan1.   

Abstract

Associations between hypertension and some cardiovascular diseases are stronger in black vs white adults. We examined associations of hypertension, hypertension duration, and control with incident heart failure (HF) in black and white REasons for Geographic And Racial Differences in Stroke study participants (n = 25 770) who were followed for incident HF hospitalization (n = 947) from enrollment in 2003-2007 through 2015. Hypertension was defined, using updated US guidelines, as systolic or diastolic blood pressure (BP) ≥130/80 mm Hg or antihypertensive medication use. Duration was assessed at baseline, and control was defined as treated BP < 130/80 mm Hg. Compared with no hypertension, hypertension was associated with higher risk of incident HF (HRwhites 1.90 [95% CI 1.49, 2.41], HRblacks 2.36 [95% CI 1.53, 3.65]), HF with preserved ejection fraction (HRwhites 2.01 [95% CI 1.34, 3.01], HRblacks 2.70 [95% CI 1.25, 2.53]), and HF with reduced/mid-range ejection fraction (HRwhites 1.69 [95% CI 1.23, 2.33], HRblacks 2.29 [95% CI 1.26, 4.15]). Hypertension duration <10 years and ≥10 years were associated with higher risk for incident HF compared with no hypertension. Although risk of incident HF was highest among participants with uncontrolled BP, even controlled BP vs no hypertension was associated with increased risk of HF (HRwhites 1.93 [95% CI 1.44, 2.58], HRblacks 2.01 [95% CI 1.22, 3.29]). Interactions with race were not statistically significant. The risk of HF associated with hypertension, even with shorter duration or controlled BP, suggests that both prevention and therapeutic management of hypertension are important in reducing HF risk.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  epidemiology; heart failure; hypertension

Mesh:

Substances:

Year:  2020        PMID: 32282123      PMCID: PMC7359908          DOI: 10.1111/jch.13856

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  36 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

2.  Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation.

Authors:  Katherine J Lee; John B Carlin
Journal:  Am J Epidemiol       Date:  2010-01-27       Impact factor: 4.897

3.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

4.  Applying Cox regression to competing risks.

Authors:  M Lunn; D McNeil
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

5.  Racial differences in the incidence of treatment for end-stage renal disease.

Authors:  S G Rostand; K A Kirk; E A Rutsky; B A Pate
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

6.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

7.  Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study .

Authors:  Ramachandran S Vasan; Joseph M Massaro; Peter W F Wilson; Sudha Seshadri; Philip A Wolf; Daniel Levy; Ralph B D'Agostino
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

8.  Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

Authors:  M Senni; C M Tribouilloy; R J Rodeheffer; S J Jacobsen; J M Evans; K R Bailey; M M Redfield
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

9.  Risk Factors for Incident Hospitalized Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal Women.

Authors:  Charles B Eaton; Mary Pettinger; Jacques Rossouw; Lisa Warsinger Martin; Randi Foraker; Abdullah Quddus; Simin Liu; Nina S Wampler; Wen-Chih Hank Wu; JoAnn E Manson; Karen Margolis; Karen C Johnson; Matthew Allison; Giselle Corbie-Smith; Wayne Rosamond; Khadijah Breathett; Liviu Klein
Journal:  Circ Heart Fail       Date:  2016-10       Impact factor: 8.790

10.  Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the Reasons for Geographic And Racial Differences in Stroke study.

Authors:  Nicole Redmond; Joshua Richman; Christopher M Gamboa; Michelle A Albert; Mario Sims; Raegan W Durant; Stephen P Glasser; Monika M Safford
Journal:  J Am Heart Assoc       Date:  2013-12-19       Impact factor: 5.501

View more
  2 in total

1.  Sleep fragmentation and incidence of congestive heart failure: the Sleep Heart Health Study.

Authors:  Bin Yan; Yanhua Wu; Xiaojuan Fan; Qun Lu; Xiancang Ma; Ling Bai
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324

2.  The association of hypertension, hypertension duration, and control with incident heart failure in black and white adults.

Authors:  Matthew T Mefford; Parag Goyal; George Howard; Raegan W Durant; Nancy E Dunlap; Monika M Safford; Paul Muntner; Emily B Levitan
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-13       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.